Skip to main content

Beginning a new era of precision Alzheimer’s therapeutics

By Inside Precision Medicine  
   April 01, 2024

The lecanemab approval last year marked what many believe is just the beginning of a new era of novel and more effective Alzheimer's therapies.

Full story

Get the latest on healthcare leadership in your inbox.